In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a GLYBURIDE AND METFORMIN HYDROCHLORIDE Drug Master File in Korea (GLYBURIDE AND METFORMIN HYDROCHLORIDE KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of GLYBURIDE AND METFORMIN HYDROCHLORIDE. The MFDS reviews the GLYBURIDE AND METFORMIN HYDROCHLORIDE KDMF as part of the drug registration process and uses the information provided in the GLYBURIDE AND METFORMIN HYDROCHLORIDE KDMF to evaluate the safety and efficacy of the drug.
After submitting a GLYBURIDE AND METFORMIN HYDROCHLORIDE KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their GLYBURIDE AND METFORMIN HYDROCHLORIDE API can apply through the Korea Drug Master File (KDMF).
click here to find a list of GLYBURIDE AND METFORMIN HYDROCHLORIDE suppliers with KDMF on PharmaCompass.